The use of liposomal doxorubicin (Myocet ® ) in the treatment of advanced breast cancer in 87-year-old woman

Abstract

Liposomal doxorubicin is used in treatment of advanced breast cancer. Structure of drug molecule allows delivery of greater total doxorubicin’s dose without escalation of adverse events. In this article treatment of elderly patient with advanced breast cancer treated before with several regimens of chemotherapy is described. After application of Myocet^® clinical regression lasted several months with important reduction of symptoms have been achieved. Tolerance of treatment was good. Until progression there were no events disrupting the rhythm and the planned dose of chemotherapy.
Onkol. Prak. Klin. 2010; supl. A: A51–A53